Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Condition: Pancreatic Cancer Interventions: Drug: FOLFIRINOX; Drug: Losartan; Drug: Nivolumab; Radiation: SBRT; Procedure: Surgery Sponsors: Massachusetts General Hospital; Bristol-Myers Squibb; Stand Up To Cancer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cozaar | Hospitals | Losartan | Pancreas | Pancreatic Cancer | Research